Search Results - "Minissale, Elena"
-
1
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity
Published in Cancer cell (13-09-2021)“…PARP7 is a monoPARP that catalyzes the transfer of single units of ADP-ribose onto substrates to change their function. Here, we identify PARP7 as a negative…”
Get full text
Journal Article -
2
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants
Published in Cell chemical biology (19-08-2021)“…PARP14 has been implicated by genetic knockout studies to promote protumor macrophage polarization and suppress the antitumor inflammatory response due to its…”
Get more information
Journal Article -
3
Abstract 1348: Targeted degradation of PARP14 Using a heterobifunctional small molecule
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract PARP14 is an interferon-stimulated gene that is overexpressed in multiple tumor types and has been shown to promote the pro-tumor M2 polarization of…”
Get full text
Journal Article -
4
Abstract 1038: A potent and selective PARP14 inhibitor decreases pro-tumor macrophage function and elicits inflammatory responses in tumor explants
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract PARPs (poly-ADP-ribose polymerases) are a family of enzymes that regulate a wide variety of important cellular processes including cellular stress…”
Get full text
Journal Article -
5
Abstract 48: RBN-2397: A potent and selective small molecule inhibitor of PARP7 that induces tumor-derived antitumor immunity dependent on CD8 T cells
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Targeting cytosolic nucleic acid sensing pathways and the Type I interferon (IFN) response is an emerging therapeutic strategy being explored in…”
Get full text
Journal Article -
6
Abstract 2154: PARP7 inhibitor RBN-2397 increases tumoral IFN signaling leading to various tumor cell intrinsic effects and tumor regressions in mouse models
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Targeting cytosolic nucleic acid sensing pathways to activate the Type I interferon (IFN) response is an emerging therapeutic strategy being explored…”
Get full text
Journal Article